Cargando…
Shengxian decoction decreases doxorubicin-induced cardiac apoptosis by regulating the TREM1/NF-κB signaling pathway
Shengxian decoction (SXT) is a traditional Chinese medicine that is clinically used for treating cardiovascular diseases. It is known for its beneficial effect on cardiomyocyte injuries, some of which can be induced by anticancer agents including doxorubicin (DOX). To determine the molecular mechani...
Autores principales: | Yao, Lei, Gui, Mingtai, Li, Jianhua, Lu, Bo, Wang, Jing, Zhou, Xunjie, Fu, Deyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845587/ https://www.ncbi.nlm.nih.gov/pubmed/33495812 http://dx.doi.org/10.3892/mmr.2021.11858 |
Ejemplares similares
-
Modified Yuejuwan Inhibited Cholesterol Accumulation and Inflammation in THP-1 Macrophage-Derived Foam Cells by Inhibiting the Activity of the TRIM37/TRAF2/NF-κB Pathway
por: Gui, Mingtai, et al.
Publicado: (2022) -
Chemical and Biological Evidence of the Efficacy of Shengxian Decoction for Treating Human Lung Adenocarcinoma
por: Li, Kejuan, et al.
Publicado: (2022) -
Huoxue Qianyang Qutan Recipe Protects against Early Renal Damage Induced by Obesity-Related Hypertension via the SIRT1/NF-κB/IL-6 Pathway: Integrating Network Pharmacology and Experimental Validation-Based Strategy
por: Wang, Mingzhu, et al.
Publicado: (2022) -
Salvianolic acid B inhibits myocardial I/R-induced ROS generation and cell apoptosis by regulating the TRIM8/GPX1 pathway
por: Lu, Bo, et al.
Publicado: (2022) -
A middle-aged male patient with de Winter syndrome: a case report
por: Lu, Bo, et al.
Publicado: (2020)